#nhs

In incredible last-day-of-trans-visibility-week news:

f1nn5ter has successfully set up her trans healthcare non-profit Anne Health

It is already the highest rated trans healthcare provider in the country apparently

Here's the page on what they actually offer

For HRT it seems to largely be about shared care agreements with GPs (-> they provide the expert info needed but your GP provides the actual meds -> better than *AHEM* other people's subscription models bc this means you can actually get your privately-prescribed meds on the NHS (how I got mine back in the day), but the downside is your GP has to be cool and not a transphobic dickhead about it (which I would generally recommend as a trait to look for in your GP))

*They can do surgical referrals but you need to check with your surgery provider if they accept them (correction bc I had not checked the FAQ properly!)

It includes trans youth!!! At least for therapy and advice around puberty blockers (again they do not provide any meds themselves)

Co-founders are former CEO of mermaids (THE trans kids charity in the UK) and founder of Think2Speak (peer support organisation)

It's a non-profit, so any money made outside of what is used on operational costs goes back into a pot to fund/subsidise people's care who can't afford it

even if you don't want to use the service itself, they also have a FAQ/resource page for general useful info

you can donate to it!!!! (there's a big donate button on the top of the page)

NHS England is violating fundamental scientific principles in its support for stopping gender affirming treatment of young people. They have excluded 97% of all trans studies to say care doesn't work. Transphobes have taken over the system.

As part of a public consultation on making masculinizing and feminizing hormones (MAF) “non-routine” for those under 18, NHS England published an Equality and Health Inequalities Impact Assessment (EHIA) dated 9 March 2026, arguing there is “very limited evidence” on safety and outcomes for young people and proposing that new prescriptions should not be routinely available through youth services.

But here's the problem: The underpinning clinical evidence reviews were designed in a way that virtually guaranteed “no evidence” conclusions.

Erin in the Morning docments that the review criteria excluded most of the real-world treatment pathway used internationally, particularly studies where puberty blockers were initiated first and hormones added later (often with an overlap period), a pattern associated with the so-called Dutch protocol.

This exclusion removed much of the most relevant adolescent literature from consideration and then treated the resulting scarcity as proof the evidence base is weak.

Alejandra Caraballo summarized the tactic over at Bluesky:

The NHS reviews reportedly screened 547 full-text papers but included only 17 (about a 96.9% exclusion rate), and split “hormones for trans adolescents” into ten fragmented reviews by regimen and by binary vs non-binary categories, leading, she says, to zero included studies in the non-binary sub-reviews because the literature rarely disaggregates outcomes that way.

She also shows that large prospective studies were excluded because cohorts weren’t separated into the highly specific subgroupings demanded by the review design.

NHS England has created an “absence of evidence” created by overly narrow inclusion rules to justify restricting care. The fact is that most experts in the field, and trans youth and their families, know that such support does help.

Pink News reports that, within the same EHIA process, NHS England also confirmed it is separately reviewing evidence on HRT for trans adults. You can bet they will fix the numbers again in order to stop trans people from getting the help they need.

As it is illegal to prescribe puberty blockers for young trans people outside of these trials, the selection process is inherently coercive thus making the trial biased. This trial will pathologise behaviour and deny dignity to the young people involved. The trials are also randomised meaning half of the participants won't even be on puberty blockers.